SPRAVATO & Ketamine

SPRAVATO® Treatment for Depression

Innovative Relief for Treatment-Resistant Depression

At Harmony Medical Associates, we are proud to offer SPRAVATO® (esketamine)—an FDA-approved nasal spray medication designed for adults struggling with treatment-resistant depression (TRD) and major depressive disorder with suicidal thoughts or actions.

SPRAVATO® works differently from traditional antidepressants by targeting glutamate receptors in the brain. This allows for faster relief of depressive symptoms in many patients when other medications have not been effective. 

What to Expect:

Is SPRAVATO® Right for You?

If you have not experienced improvement with multiple antidepressants, SPRAVATO® may be an appropriate next step. Our clinicians will evaluate your history and create a customized treatment plan to determine your eligibility.

IV Ketamine Therapy for Depression & Mood Disorders

A Breakthrough Option for Treatment-Resistant Depression At Harmony Medical Associates, we offer intravenous (IV) ketamine therapy as a cutting-edge treatment for individuals experiencing treatment-resistant depression, bipolar depression, PTSD, and certain chronic pain syndromes. Ketamine, originally developed as an anesthetic, has shown rapid and robust effects in improving mood and reducing suicidal thoughts—even when traditional medications have not worked.

How IV Ketamine Therapy Works:

Who Is It For?

IV ketamine may be appropriate for adults who: